| Reprogramming exosomes as nanoscale controllers of cellular immunity Q Cheng, X Shi, M Han, G Smbatyan, HJ Lenz, Y Zhang Journal of the American Chemical Society 140 (48), 16413-16417, 2018 | 227 | 2018 |
| The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells Q Cheng, H Shi, H Wang, Y Min, J Wang, Y Liu Chemical Communications 50 (56), 7427-7430, 2014 | 168 | 2014 |
| Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy X Shi, Q Cheng, T Hou, M Han, G Smbatyan, JE Lang, AL Epstein, ... Molecular therapy 28 (2), 536-547, 2020 | 165 | 2020 |
| Multifunctional platinum‐based nanoparticles for biomedical applications Q Cheng, Y Liu Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9 (2), e1410, 2017 | 63 | 2017 |
| Human serum albumin conjugated nanoparticles for pH and redox‐responsive delivery of a prodrug of cisplatin H Shi, Q Cheng, S Yuan, X Ding, Y Liu Chemistry–A European Journal 21 (46), 16547-16554, 2015 | 57 | 2015 |
| Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles ZT Cao, ZY Chen, CY Sun, HJ Li, HX Wang, QQ Cheng, ZQ Zuo, JL Wang, ... Biomaterials 94, 9-19, 2016 | 53 | 2016 |
| Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles Q Cheng, H Shi, H Huang, Z Cao, J Wang, Y Liu Chemical communications 51 (99), 17536-17539, 2015 | 52 | 2015 |
| Asplatin enhances drug efficacy by altering the cellular response Q Cheng, H Shi, H Wang, J Wang, Y Liu Metallomics 8 (7), 672-678, 2016 | 43 | 2016 |
| Cisplatin binds to human copper chaperone Cox17: the mechanistic implication of drug delivery to mitochondria L Zhao, Q Cheng, Z Wang, Z Xi, D Xu, Y Liu Chemical communications 50 (20), 2667-2669, 2014 | 42 | 2014 |
| Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells Y Ma, Q Cheng, Z Ren, L Xu, Y Zhao, J Sun, S Hu, W Xiao Cancer letters 317 (2), 150-156, 2012 | 40 | 2012 |
| A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation XN Zhang, Q Cheng, J Chen, AT Lam, Y Lu, Z Dai, H Pei, NM Evdokimov, ... Nature communications 10 (1), 4196, 2019 | 32 | 2019 |
| Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes Q Cheng, Z Dai, G Smbatyan, AL Epstein, HJ Lenz, Y Zhang Molecular Therapy 30 (9), 3066-3077, 2022 | 27 | 2022 |
| Synthesis of site-specific antibody-drug conjugates by ADP-ribosyl cyclases Z Dai, XN Zhang, F Nasertorabi, Q Cheng, J Li, BB Katz, G Smbatyan, ... Science Advances 6 (23), eaba6752, 2020 | 27 | 2020 |
| Reprogramming exosomes for immunotherapy Q Cheng, X Shi, Y Zhang Cell Reprogramming for Immunotherapy: Methods and Protocols, 197-209, 2020 | 25 | 2020 |
| A cell-penetrating protein designed for bimodal fluorescence and magnetic resonance imaging Q Wu, Q Cheng, S Yuan, J Qian, K Zhong, Y Qian, Y Liu Chemical Science 6 (11), 6607-6613, 2015 | 25 | 2015 |
| Facile chemoenzymatic synthesis of a novel stable mimic of NAD+ Z Dai, XN Zhang, F Nasertorabi, Q Cheng, H Pei, SG Louie, RC Stevens, ... Chemical science 9 (44), 8337-8342, 2018 | 19 | 2018 |
| Reprogramming extracellular vesicles with engineered proteins X Shi, Q Cheng, Y Zhang Methods 177, 95-102, 2020 | 18 | 2020 |
| Expanding the toolbox of exosome-based modulators of cell functions Q Cheng, Z Dai, X Shi, X Duan, Y Wang, T Hou, Y Zhang Biomaterials 277, 121129, 2021 | 16 | 2021 |
| Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum (II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum (II) D Xu, Y Min, Q Cheng, H Shi, K Wei, F Arnesano, G Natile, Y Liu Journal of Inorganic Biochemistry 129, 15-22, 2013 | 16 | 2013 |
| Rational design of a humanized antibody inhibitor of cathepsin B Z Dai, Q Cheng, Y Zhang Biochemistry 59 (14), 1420-1427, 2020 | 14 | 2020 |
Yz LiuUSTCVerified email at ustc.edu.cn
